Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;23(4):293-303.
doi: 10.1016/j.smim.2011.04.002. Epub 2011 May 26.

Costimulatory pathways in transplantation

Nina Pilat  1 , Mohamed H Sayegh, Thomas Wekerle
Affiliations

Costimulatory pathways in transplantation

Nina Pilat et al. Semin Immunol. 2011 Aug.

Abstract

Secondary, so-called costimulatory, signals are critically required for the process of T cell activation. Since landmark studies defined that T cells receiving a T cell receptor signal without a costimulatory signal, are tolerized in vitro, the investigation of T cell costimulation has attracted intense interest. Early studies demonstrated that interrupting T cell costimulation allows attenuation of the alloresponse, which is particularly difficult to modulate due to the clone size of alloreactive T cells. The understanding of costimulation has since evolved substantially and now encompasses not only positive signals involved in T cell activation but also negative signals inhibiting T cell activation and promoting T cell tolerance. Costimulation blockade has been used effectively for the induction of tolerance in rodent models of transplantation, but turned out to be less potent in large animals and humans. In this overview we will discuss the evolution of the concept of T cell costimulation, the potential of 'classical' and newly identified costimulation pathways as therapeutic targets for organ transplantation as well as progress towards clinical application of the first costimulation blocking compound.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Costimulatory pathways relevant in transplantation. (a) Expression patterns of costimulatory molecules on T cells and APC are depicted. Categorization according to structure and function as positive or negative signalling pathway are indicated. (b) Costimulation blockers in (pre)clinical development and their ligands are depicted. Signals inhibited by these compounds are shown in grey.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lamb K.E., Lodhi S., Meier-Kriesche H.U. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2010;11:450–462. - PubMed
    1. Rosenberg A.S., Mizuochi T., Sharrow S.O., Singer A. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med. 1987;165:1296–1315. - PMC - PubMed
    1. Lafferty K.J., Cunningham A.J. A new analysis of allogeneic interactions. Aust J Exp Biol Med Sci. 1975;53:27–42. - PubMed
    1. Jenkins M.K., Schwartz R.H. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med. 1987;165:302–319. - PMC - PubMed
    1. Li X.C., Rothstein D.M., Sayegh M.H. Costimulatory pathways in transplantation: challenges and new developments. Immunol Rev. 2009;229:271–293. - PubMed

Publication types